News

MitoSense, Inc. has announced a strategic partnership with Aquila Health PBC, a healthcare data infrastructure company, to create an artificial intelligence-ready data foundation for its research, future clinical programs, and commercial activities. Built on Aquila's TREUE™ standard, the collaboration will create a governed, longitudinal data foundation for mitochondrial medicine.

Collaboration will evaluate mitochondrial and microRNA biomarkers, multi-omics analysis, and research tools relevant to astronaut health, deep-space travel, and post-viral disease PLYMOUTH, Mass., July 13, 2026 – MitoSense , Inc., a biotechnology company focused on mitochondrial health and mitochondrial organelle transplantation technologies, today announced that it has signed a Memorandum of Understanding with the University of Pittsburgh to explore research opportunities at

MitoSense is proud to be featured by Dr. Robert Lufkin MD, one of the leading voices in metabolic health and longevity, in his widely read Substack and popular YouTube series. In his recent Substack article "Can a Transplant Cure Aging? The Next Frontier in Longevity Medicine," Dr. Lufkin explores mitochondrial dysfunction as a shared upstream driver of aging and chronic diseases, including ALS, Parkinson’s, Alzheimer’s, stroke, and type 2 diabetes. Dr. Lufkin spotlights Mit

MitoSense Inc. congratulates its partner, Greenwood Genetic Center (GGC), on receiving $1,106,000 in new federal funding to advance Alzheimer’s disease research and on the publication of a new peer reviewed genetic study from the same Alzheimer’s Initiative team demonstrating the impact of mitochondrial transplantation on cellular energy production. The federal funding , supported by U.S. Senator Lindsey Graham and awarded through the U.S. Department of Health and Human Servi

February 6, 2026 – Plymouth, MA – MitoSense, Inc., a biotechnology company advancing mitochondrial-based therapies, is proud to announce its sponsorship of Countdown For A Cure (CFAC) and to congratulate the organization on the success of its annual signature event. Countdown For A Cure is a nonprofit organization dedicated to advancing mitochondrial research and increasing awareness of the critical role cellular energy plays in health, disease prevention, and longevity. Thro

MitoSense, Inc. is proud to announce its participation in the 2025 Military Health System Research Symposium (MHSRS), taking place August...